Chronic administration of the selective P2X3, P2X2/3 receptor antagonist, A-317491, transiently attenuates cancer-induced bone pain in mice.
European journal of pharmacology • Vol. 688, Issue 1-3 • 2012
P2 receptor antagonists prevent synaptic failure and extracellular signal-regulated kinase 1/2 activation induced by oxygen and glucose deprivation in rat CA1 hippocampus in vitro.
The European journal of neuroscience • Vol. 33, Issue 12 • 2011
Involvement of enkephalins in the inhibition of osteosarcoma-induced thermal hyperalgesia evoked by the blockade of peripheral P2X3 receptors.
Neuroscience letters • Vol. 465, Issue 3 • 2009
Roles of peripheral P2X and P2Y receptors in the development of melittin-induced nociception and hypersensitivity.
Neurochemical research • Vol. 33, Issue 10 • 2008
